Standardising CAR T-Cell Monitoring to Improve Clinical Insights & Translational Outcomes

• Highlight approaches to monitor CAR T-cells consistently during production and in patients
• Explore how monitoring informs therapy development, safety, and efficacy assessments
• Discuss the potential for standardised monitoring to guide clinical decisions and improve outcomes

Speakers:

Mohamed Awwad

Group Leader

Heidelberg University Hospital